Implementation sits outside Part D, with Humana handling PA, adjudication, and reimbursement; manufacturers provide a $245 net price for Wegovy, Zepbound, and orforglipron. Eligibility requires PA and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results